|
|
|
Volumn 303, Issue 5659, 2004, Pages 745-
|
|
FDA Weighs Suicide Risk in Children on Antidepressants
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
FLUOXETINE;
PAROXETINE;
PLACEBO;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
AGITATION;
ANXIETY DISORDER;
ATTENTION DEFICIT DISORDER;
AUTOMUTILATION;
CHILD;
CLINICAL TRIAL;
DEPRESSION;
DRUG EFFICACY;
DRUG INFORMATION;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
HOMICIDE;
HOSTILITY;
HUMAN;
MEDICAL SOCIETY;
NOTE;
OBSESSIVE COMPULSIVE DISORDER;
PRESCRIPTION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SIDE EFFECT;
SUICIDAL BEHAVIOR;
SUICIDE;
ADOLESCENT;
ADVISORY COMMITTEE;
ARTICLE;
CONTROLLED CLINICAL TRIAL;
POSTMARKETING SURVEILLANCE;
RISK FACTOR;
UNITED KINGDOM;
UNITED STATES;
ADOLESCENT;
ADVISORY COMMITTEES;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
ANXIETY DISORDERS;
CHILD;
CONTROLLED CLINICAL TRIALS;
DEPRESSIVE DISORDER;
GREAT BRITAIN;
HUMANS;
PRODUCT SURVEILLANCE, POSTMARKETING;
RISK FACTORS;
SEROTONIN UPTAKE INHIBITORS;
SUICIDE;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0842309886
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (20)
|
|
References (0)
|